Tg Therapeutics (TGTX) Other Working Capital Changes (2011 - 2026)

Tg Therapeutics' Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$10.7 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 1863.35% year-over-year to -$10.7 million; the TTM figure through Mar 2026 stood at $32.3 million (up 1014.58% YoY), while the FY2018 annual figure was -$152000.0, changed N/A from the prior year.
• Other Working Capital Changes was -$10.7 million for Q1 2026 at Tg Therapeutics, down from $44.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $44.0 million in Q4 2025 to a low of -$11.5 million in Q3 2025.
• Historically, Other Working Capital Changes has averaged $1.6 million across 5 years, with a median of -$593000.0 in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes slumped 2923.68% in 2023, then surged 7459.53% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$6.4 million in 2022, then soared by 216.32% to $7.5 million in 2023, then slumped by 107.98% to -$598000.0 in 2024, then soared by 7459.53% to $44.0 million in 2025, then slumped by 124.22% to -$10.7 million in 2026.
• The last three Other Working Capital Changes figures came in at -$10.7 million (Q1 2026), $44.0 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.